GeneInCell-The AI-powered Biotech Podcast focuses on crisp, science-based podcasts on stem cells, organoids, and gene editing—tracking breakthroughs from bench to bedside for better human health, including Biotech and business.
GeneInCell
Claim This Podcastby Vinod Reddy Lekkala
5.0(1 reviews)
37 episodes
Updated Daily
Accepts GuestsHas Sponsors
Podcast Overview
GeneInCell-The AI-powered Biotech Podcast focuses on crisp, science-based podcasts on stem cells, organoids, and gene editing—tracking breakthroughs from bench to bedside for better human health, including Biotech and business.
Language
🇺🇲
Publishing Since
8/11/2025
1 verified contact email on file for GeneInCell
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 28, 2026
Can Epigenetic Reprogramming Reverse Aging? | GeneInCell | 2026
<p>Epigenetic reprogramming is emerging as one of the most intriguing ideas in aging research—the possibility that aging is not just damage, but also a reversible loss of cellular identity. In this episode, we explore how scientists are trying to reset the epigenetic instructions that control gene expression, tissue function, and biological age. We break down the science behind partial reprogramming, what preclinical studies suggest about rejuvenation, regeneration, and lifespan-related outcomes, and why safety, durability, and cancer risk remain major challenges. Can aging really be reversed, or are we only beginning to understand the code that drives it?</p><p><br></p>
June 22, 2026
Chemical Antibodies: How Aptamers Could Transform Future Therapies | GeneInCell | 2026
<p>Aptamers are emerging as powerful “chemical antibodies” that can bind targets with high precision while offering advantages in design, synthesis, and stability. In this episode, we explore how these short nucleic acid ligands are selected, how they work, and why they are gaining attention as next-generation tools for diagnostics, targeted delivery, and therapy. We also discuss their potential to reshape future medicine, along with the key challenges that must be solved for broader clinical use.</p><p><br></p>
June 15, 2026
Antisense Oligonucleotides: Programming RNA to Silence Disease | GeneInCell | 2026
<p>Antisense oligonucleotides are redefining medicine by programming RNA to silence disease at its source. In this episode, we explore how these short, sequence-designed molecules bind target RNA to reduce harmful protein production, reshape splicing, and open new possibilities for precision therapeutics. We cover the history, mechanism, chemistry, and growing clinical relevance of ASOs, along with their promise and limitations in treating genetic, neurological, retinal, muscular, liver, and rare diseases.</p><p><br></p>
37 total episodes available
Deep-dive analytics for GeneInCell
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is GeneInCell?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.